In addition, serum insulin and glucose levels were unchanged (p = 0.5631) and increased non-significantly (p = 0.0531), respectively, in NAFLD patients compared to non-NAFLD individuals, indicating insulin resistance in NAFLD patients (Figures 8E and 8F). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.